Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
D000638:Amiodarone / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001073:Aprindine / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004206:Disopyramide / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008012:Lidocaine / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D016677:Tocainide
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D008801:Mexiletine; D016677:Tocainide; D001073:Aprindine; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D004206:Disopyramide; D011342:Procainamide; D000638:Amiodarone